TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Phage Therapy market size is estimated to be $47 million in 2023, and MAResearch analysts predict it will reach $72 million by 2032, growing at a CAGR of 4.9% during the forecast period from 2024 to 2032.
The USA market for Global Phage Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Phage Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Phage Therapy market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report studies the Phage Therapy market, covering market size for segment by type (DsDNA Bacteriophage, SsDNA Bacteriophage, etc.), by application (Animal Health, Human Health, etc.), by sales channel (Direct Channel, Distribution Channel), by player (NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Phage Therapy from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Phage Therapy market.
Leading Players of Phage Therapy including:
